Struggling to decode a complex lab report? OpenAI has a solution. Enter ChatGPT Health-a new, dedicated mode designed to make ...
In idiopathic pulmonary fibrosis, 12 months of pulmonary rehabilitation increased cerebral oxygenation during exercise, ...
CT scan of chest, abdomen, and pelvis shows high-disease burden, including multiple mediastinal and hilar nodes, deposits in ...
January is National Blood Donor Month, and LifeSouth Community Blood Centers is encouraging regular donors and those who have ...
Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...
Sparrow Pharmaceuticals, a targeted cardiometabolic therapeutics company, today announced that the first patient has been ...
The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.
Verywell Health on MSN
4 supplements to take with vitamin C for better absorption
Medically reviewed by Paria Sanaty Zadeh, PharmD Vitamin C can increase the absorption of iron, an essential mineral. Vitamin ...
People with thalassemia may be at higher risk of getting COVID-19 because of frequent hospital visits. Thalassemia can make COVID-19 outcomes worse due to other health problems, like heart or liver ...
Verywell Health on MSN
9 nutrient-rich nuts packed with protein, fiber, and healthy fats
Medically reviewed by Jamie Johnson, RDN Nuts are a crunchy, satisfying snack packed with fiber, protein, and healthy fats.
Idorsia receives approval from Health Canada for JERAYGO (aprocitentan) as the first and only endothelin receptor antagonist (ERA) for the treatment of resistant hypertension.JERAYGO is a new oral ant ...
Emmaus Life Sciences has entered into an agreement to sell the North American rights to its oral sickle cell disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results